Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
New England Investors
Darien, Connecticut, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
New England Investors is an advisory firm providing strategic, financial, and licensing advisory services to North American and European biotech and pharma companies, focusing heavily on monetizing early- and mid-stage assets via out-licensing to China and cross-border transactions[2][6].
- Industry
- Consulting
02
Partnerships
Virpax Pharmaceuticals (engaged as out-licensing advisor)[2]
Beyond the preview
Go deeper on New England Investors.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on New England Investors.